A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes
Reads0
Chats0
TLDR
Wang et al. as discussed by the authors presented psychotropic drugs used in patients with bipolar disorder, and accessed changes of psychotropic drug treatments in acute and maintenance episodes by retrospectively evaluating the medical records of inpatients in the Ningbo Kangning Hospital from January 2019 to December 2019.Abstract:
Background Bipolar disorder (BD) is predominantly treated with psychotropic drugs, but BD is a complex medical condition and the contribution of psychotropic drugs is not clear. The objectives of this study are: (1) to present psychotropic drugs used in patients with BD; (2) to access changes of psychotropic drug treatments in acute and maintenance episodes. Methods The study retrospectively evaluated the medical records of inpatients in the Ningbo Kangning Hospital from January 2019 to December 2019. The medical history of each subject was collected completely, including sociodemographic (gender, age, marital status, and so on) and clinical characteristics at baseline and within 12 months of admission. Results The study ultimately included 204 patients with BD. After 12 months, 73.0% of the patients still took drugs. Mood stabilizers (72–90%) and antipsychotics (77–95%) were still the most important drugs in patients with BD. Antidepressants (34–40%) and benzodiazepines (20–34%) were the other frequently used drug classes. For mood stabilizers, 40–56% of patients were prescribed lithium. For antipsychotic, 54–65% of patients were prescribed quetiapine. Sertraline (6–9%) and fluoxetine (5–9%) were the antidepressant that most frequently prescribed. Lorazepam (10–18%) was the most commonly used benzodiazepine. In psychotropic polypharmacy, the most frequently taken was mood stabilizer plus antipsychotic co-treatment, about 36–44% of all patients. A total of 35–48% of patients treated by two psychotropic drugs and 24–36% received three. Conclusion The first 6 months after treatment is very important to medication adherence. Mood stabilizers and antipsychotic remained the primary treatment for BD. Antipsychotic is on the rise in the treatment of BD.read more
Citations
More filters
Journal ArticleDOI
Effects of exogenous melatonin on sleep and circadian rhythm parameters in bipolar disorder with comorbid delayed sleep-wake phase disorder: An actigraphic study
F. Cruz-Sanabria,Ugo Faraguna,Miriam Violi,S. Bruno,David Gravina,Chiara Bonelli,Andrea Bazzani,Leonardo Massoni,Laura Musetti,Marly Simoncini,Paolo Frumento,Liliana Dell'Osso,Claudia Carmassi +12 more
References
More filters
Journal ArticleDOI
Systematic review and meta-analysis
TL;DR: In this review the usual methods applied in systematic reviews and meta-analyses are outlined, and the most common procedures for combining studies with binary outcomes are described, illustrating how they can be done using Stata commands.
Journal ArticleDOI
Retrospective study: The diagnostic accuracy of conventional forceps biopsy of gastric epithelial compared to endoscopic submucosal dissection (STROBE compliant).
TL;DR: According to the analysis, old men plus gastric fundus or antrum of CFB were strongly suggested to perform ESD if precancerous lesions were found and young women with low-grade intraepithelial neoplasia could select regular follow-up.
Journal ArticleDOI
Policy and Research Related to Consumer Rebates: A Comprehensive Review:
Cornelia Pechmann,Tim Silk +1 more
TL;DR: In this paper, the authors present the first comprehensive, multidisciplinary review of consumer rebates that includes federal regulations, state laws, and academic research, and identify federal guidelines for rebates by reviewing the 18 Federal Trade Commision rebate-related complaints and the associated consent decrees.
Journal ArticleDOI
Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.
Kathleen R. Merikangas,Robert Jin,Jian-Ping He,Ronald C. Kessler,Sing Lee,Nancy A. Sampson,Maria Carmen Viana,Laura Helena Andrade,Chiyi Hu,Elie G. Karam,Maria Ladea,María Elena Medina-Mora,Yutaka Ono,Jose Posada-Villa,Rajesh Sagar,J. Elisabeth Wells,Zahari Zarkov +16 more
TL;DR: The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS.
Journal ArticleDOI
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Guy M. Goodwin,Peter M. Haddad,I. N. Ferrier,Jeffrey K Aronson,T R H Barnes,Andrea Cipriani,David Coghill,Seena Fazel,John R. Geddes,Heinz Grunze,Emily A. Holmes,Oliver D. Howes,S. Hudson,N. Hunt,Ian Jones,Iain Macmillan,H. McAllister-Williams,D. R. Miklowitz,Richard Morriss,Marcus R. Munafò,Carol Paton,B. J. Saharkian,Kate E. A. Saunders,Julia Sinclair,David Taylor,Eduard Vieta,Allan H. Young +26 more
TL;DR: The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.